BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19549787)

  • 1. Aortic aneurysm in MAGIC syndrome successfully managed with combined anti-TNF-alpha and stent grafting.
    Mekinian A; Lambert M; Beregi JP; Morell-Dubois S; Launay D; Queyrel V; Midulla M; Hachulla E; Hatron PY
    Rheumatology (Oxford); 2009 Sep; 48(9):1169-70. PubMed ID: 19549787
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.
    Geissal ED; Wernick R
    J Clin Rheumatol; 2010 Jun; 16(4):185-7. PubMed ID: 20414125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aneurysmatic aortitis in the MAGIC syndrome].
    Fernández-Monrás F; Fornós C; Argimón J; Pujadas R
    Med Clin (Barc); 1997 Nov; 109(17):684-5. PubMed ID: 9488961
    [No Abstract]   [Full Text] [Related]  

  • 4. Transverse aortic arch replacement associated with MAGIC syndrome: case report and literature review.
    Caceres M; Estrera AL; Buja LM; Safi HJ
    Ann Vasc Surg; 2006 May; 20(3):395-8. PubMed ID: 16779521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome complicated by aneurysmal aortitis.
    Ng CS; Hogan P; McKenzie S; Gibbs H; Strutton G; Wong R
    J Clin Rheumatol; 2007 Aug; 13(4):221-3. PubMed ID: 17762460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis.
    Jabbarvand M; Fard MA
    Ocul Immunol Inflamm; 2010 Jun; 18(3):216-7. PubMed ID: 20482401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
    Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract]   [Full Text] [Related]  

  • 8. Magic syndrome and true aortic aneurysm.
    Hidalgo-Tenorio C; Sabio-Sánchez JM; Linares PJ; Salmerón LM; Ros-Die E; Jiménez-Alonso J
    Clin Rheumatol; 2008 Jan; 27(1):115-7. PubMed ID: 17657547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of tocilizumab therapy in a patient with mouth and genital ulcers with inflamed cartilage syndrome complicated by aortic aneurysm.
    Terreaux W; Mestrallet S; Fauconier M; Pennaforte JL; Penalba C; Eschard JP; Salmon JH
    Rheumatology (Oxford); 2015 Nov; 54(11):2111-3. PubMed ID: 26175469
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behçet's disease and relapsing polychondritis (MAGIC syndrome) associated with antiphospholipid syndrome].
    Gamboa F; Rivera JM; Mayoral L; Grilo A
    Med Clin (Barc); 1998 May; 110(17):678-9. PubMed ID: 9656217
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
    Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
    Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-TNF-alpha therapy for uveitis: Behçet and beyond.
    Murray PI; Sivaraj RR
    Eye (Lond); 2005 Aug; 19(8):831-3. PubMed ID: 16086039
    [No Abstract]   [Full Text] [Related]  

  • 13. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.
    Cazabon S; Over K; Butcher J
    Eye (Lond); 2005 Feb; 19(2):222-4. PubMed ID: 15258602
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.
    Mpofu S; Estrach C; Curtis J; Moots RJ
    Rheumatology (Oxford); 2003 Sep; 42(9):1117-8. PubMed ID: 12923271
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement.
    Marie I; Lahaxe L; Josse S; Levesque H
    Rheumatology (Oxford); 2009 Oct; 48(10):1328-9. PubMed ID: 19651886
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapsing polychondritis--a case report and review of literature.
    Sunder S; Rath PC; Jairaj PS; Krishnaswami S
    J Assoc Physicians India; 1989 Apr; 37(4):285-7. PubMed ID: 2693438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGIC or not MAGIC--does the MAGIC (mouth and genital ulcers with inflamed cartilage) syndrome really exist? A case report and review of the literature.
    Kötter I; Deuter C; Günaydin I; Zierhut M
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S108-12. PubMed ID: 17067439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha.
    Keijzer A; van der Valk P; Ossenkoppele GJ; van de Loosdrecht AA
    Haematologica; 2006 Dec; 91(12 Suppl):ECR51. PubMed ID: 17194657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease.
    Firestein GS; Gruber HE; Weisman MH; Zvaifler NJ; Barber J; O'Duffy JD
    Am J Med; 1985 Jul; 79(1):65-72. PubMed ID: 4014306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of infliximab.
    Firinu D; Frau A; Pisanu M; Lorai MM; Meleddu R; Musu F; Manconi PE; Del Giacco SR
    J Biol Regul Homeost Agents; 2012; 26(4):785-8. PubMed ID: 23241130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.